Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-18

Clinical Trial Update: Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rabbit antithymocyte globulin (Thymoglobuline) with Ciclosporin for acquired aplastic anaemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciclosporin (cyclosporine)
  • rabbit antithymocyte globulin (Thymoglobuline) (thymoglobulin (rab-ATG))

Snippet

Sponsor: European Society for Blood and Marrow Transplantation | Conditions: Aplastic Anemia | Phase 2 | Status: COMPLETED | Results posted: 2021-10-18